State of Wyoming »

Protalix Biotherapeutics shares owned by State of Wyoming

Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by State of Wyoming from 13F filings

Historical chart of State of Wyoming investment in Protalix Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protalix Biotherapeutics held by State of Wyoming consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protalix Biotherapeutics by State of Wyoming

Quarter filed Position value Share count Share price at filing
2025-09-30 $87k 39k 2.22
2023-09-30 $69k 41k 1.66

More positions owned by State of Wyoming

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Msci Eafe Etf (EFA)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Msci Emrg Chn (EMXC)
Ies Hldgs (IESC)
Meta Platforms Cl A (META)
Ishares Tr Msci Acwi Ex Us (ACWX)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Msci Taiwan Etf (EWT)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Msci India Etf (INDA)
Ishares Msci Cda Etf (EWC)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)

View all positions for State of Wyoming

Top funds holding Protalix Biotherapeutics

BlackRock
Opaleye Management
Renaissance Technologies
Northern Trust
Geode Capital Management
Stratos Wealth Partners
State Street Corporation
Vanguard Group
Morgan Stanley
Connor, Clark & Lunn Investment Management
UBS Group
Bridgeway Capital Management
Diametric Capital
Charles Schwab Investment Management
Commonwealth Equity Services

View all funds holding Protalix Biotherapeutics